RVTY vs SOLV — Key Metrics

Metric RVTY (REVVITY INC) SOLV (SOLVENTUM CORP)
Price152.4386.48
Market Cap17.02 Billion14.68 Billion
P/E (TTM)67.7597.17
P/B (Quarterly)2.4433.08
P/S (TTM)5.781.8
Net Profit Margin (TTM)8.61.9
Gross Margin (TTM)55.954.8
ROE (TTM)3.53.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

REVVITY INC
vs
 
SOLVENTUM CORP
 
REVVITY INC
vs
 
SOLVENTUM CORP
Performance Comparison
AI Model Recommendation
RVTY · REVVITY INC

Underperform

-46
UnderperformOutperform
SOLV · SOLVENTUM CORP

Outperform

38
UnderperformOutperform
Recommendation Summary

Stock RVTY is projected to underperform the market, stock SOLV is projected to outperform the market. Upfront Recommendation: SOLV.

Financial Metrics
Prices delayed ~15 min
RVTY Metrics SOLV
$152.43 Price $86.48
— Market Capitalization —
67.75 Price to Earnings Ratio 97.17
5.78 Price to Sales 1.8
28.24 Price to FCF Ratio 47.65
10.35 Price to Gross Profit 3.28
79.84 Price to R&D 20.3
9.14 Price to Current Assets 3.98

RVTY vs SOLV at a glance

Revvity INC (RVTY) and Solventum Corp (SOLV) are both in the Healthcare sector. RVTY is the larger, at $17.0 billion in market value against $14.7 billion for SOLV, about 1.2 times the size.

On trailing-twelve-month figures, RVTY trades at 67.8 times trailing earnings and SOLV at 97.2; net profit margins are 8.6% and 1.9%.

The Upfront Investment model currently rates RVTY Underperform and SOLV Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.